MIRdetect raises €800K Pre-Seed round
14 October 2016· Bremerhaven, Germany· health, manufacturing, biotech, b2b, software_hardware
The funding from the EXIST research transfer program was used to develop a new diagnostic procedure for the early detection of testicular cancer and to prepare for a company spin-off
Investors
LeadBundesministerium für Wirtschaft und Energie
Also participating
Europäischer Sozialfonds
About MIRdetect
Stage
Pre-Seed
Headquarters
Bremerhaven, Germany
Founded
2015
Team Size
6–20
Sectors
healthmanufacturingbiotechb2bsoftware_hardware